Tweak to pritelivir allows treatment of latent herpes infections

Pandemic adolescent mental health study reveals turnaround finding
17 June 2021
Study reveals multiple benefits of Mediterranean diet for patients with lupus
17 June 2021

Tweak to pritelivir allows treatment of latent herpes infections

A team of researchers at Innovative Molecules GmbH, working with several other institutions in Germany, has developed a small-molecule therapy for the treatment of latent herpes simplex virus infections. In their paper published in the journal Science Translational Medicine, the group describes tweaking a drug used for treating active herpes infections for treatments of both active and latent herpes infections in rodents.

Comments are closed.